Tenzing Acquisition Corp. Units
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TZACU and buy or sell other stocks, ETFs, and their options commission-free!About TZACU
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines.
CEOLaxminarayan Bhat, PhD
CEOLaxminarayan Bhat, PhD
Employees14
Employees14
HeadquartersCupertino, California
HeadquartersCupertino, California
Founded2020
Founded2020
Employees14
Employees14
TZACU Key Statistics
Market cap1.11B
Market cap1.11B
Price-Earnings ratio-92.67
Price-Earnings ratio-92.67
Dividend yield—
Dividend yield—
Average volume1.14K
Average volume1.14K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$23.70
52 Week high$23.70
52 Week low$10.20
52 Week low$10.20
Stock Snapshot
With a market cap of 1.11B, Tenzing Acquisition Corp. Units(TZACU) trades at $11.50. The stock has a price-to-earnings ratio of -92.67.
During the trading day, Tenzing Acquisition Corp. Units(TZACU) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.14K.
The stock's 52-week range extends from a low of $10.20 to a high of $23.70.
The stock's 52-week range extends from a low of $10.20 to a high of $23.70.